Ablatherm HIFU
8Pages

{{requestButtons}}

Catalog excerpts

Ablatherm HIFU - 1

The Must-have Complement to Surgery THE NON-INVASIVE THERAPY FOR LOCALIZED PROSTATE CANCER Focal treatment Primary treatment Local recurrence after radiation therapy

Open the catalog to page 1
Ablatherm HIFU - 2

The Must-have Complem Patients live longer with prostate cancer Diagnosis Life expectancy Life expectancy Focal control of prostate cancer The perfect balance between active surveillance and overtreatment Pinpoint treatment of cancer focus Treatment of a single prostate lobe with preservation of neurovascular bundle on one side Preservation of neurovascular bundles on one or on both sides Ideal focal treatment therapy Proven ablation Ablatherm® HIFU combines all the required features of the ideal focal therapy Real-time monitoring Preserves quality of life All treatments remain salvage...

Open the catalog to page 2
Ablatherm HIFU - 3

ment to Surgery 1990 Patient lived 7 years with prostate cancer Treatment strategy --› Efcacy at any cost • Single treatment approach • Agressive radical surgery • Radical radiotherapy 2010 Patient lived 15 years with prostate cancer Treatment strategy --› Disease control with quality of life preservation • Multi-treatment approach for resistant disease • Non-invasive techniques • Focal therapy Ablatherm® HIFU enables implementation of the optimal treatment strategies for new prostate cancer patients • Strong will to preserve quality of life • Non-invasive treatment • Multi-treatment...

Open the catalog to page 3
Ablatherm HIFU - 4

Tailor your patient’s treatm State-of-the-art Ablatherm® HIFU technology • Truly non-invasive • Precise • Repeatable • Multi-modal • Radiation free • Fully robotic • Specic validated protocols for primary, salvage and repeat treatment Endorectal probe Therapy transducer 3MHz Imaging transducer 7.5MHz 3 steps for robotic non-invasive treatment Treatment planning • Fully adjustable treatment parameters to suit all prostate anatomies 3D imaging • 3D imaging of the prostate with 7.5MHz transducer Robotic treatment • Robotic treatment of the prostate following the treatment plan Treatment module...

Open the catalog to page 4
Ablatherm HIFU - 5

ment with Ablatherm® HIFU Focus point High Intensity Focused Ultrasound principles • Thermal effect: fast temperature rise above 80°C • Mechanical effect: generation and collapse of gas bubbles, ruptures cell walls • Immediate coagulation necrosis followed by brosis Automated Safety Features Rectal wall HIFU transducer Rectal cooling system • Active liquid cooling • Real-time monitoring of rectal wall temperature • Prevention of stulas External patient movement detector • Movements are monitored in real-time • Treatment is stopped automatically if a movement is detected Fistula prevention...

Open the catalog to page 5
Ablatherm HIFU - 6

Negative biopsie rate Mean follow-up (months) High risk Intermediate risk Excellent morbidity prole and quality of life preservation after primary Ablatherm® HIFU treatment • No late onset morbidity • High preservation of potency with nerve-sparing strategy: 87%(1) • Low incontinence rate: 7% moderate incontinence(4) and 0% severe incontinence(11) • Recto-urethral stula rate <0.5%(33) Promising long-term results for focal therapy Efcacy of focal Ablatherm® HIFU treatment: 90% at 5 years(32) Excellent treatment tolerance without side effects: • No incontinence reported • No urethral...

Open the catalog to page 6
Ablatherm HIFU - 7

Proven reproducible efcacy and preserved quality of life For primary, salvage treatment after EBRT and focal strategy, Ablatherm® HIFU shows excellent cancer control and morbidity prole Large cohort publications demonstrate: • Long-term disease control • Low morbidity • Reproducibility Ablatherm® HIFU treatment registry Online patient management database to improve the understanding of prostate HIFU outcomes • Central online Ablatherm® HIFU registry • Practice management tool for real-time statistical feedback • User-friendly follow-up database • Support for clinical publication statistics...

Open the catalog to page 7
Ablatherm HIFU - 8

EDAP TMS is the leader in therapeutic ultrasound. Having been present in the market for 30 years, EDAP TMS (NASDAQ: EDAP) develops minimally-invasive therapeutic solutions for urology. By consistently investing in research and development and by forming partnerships with internationally-renowned medical research institutions, EDAP TMS has been able to patent innovative technologies. EDAP TMS is present in many countries via an extensive network of Subsidiaries and Distribution Partners. The Company focuses on producing a high standard of service for health care practitioners: mobile...

Open the catalog to page 8

All EDAP TMS catalogs and technical brochures

Archived catalogs